Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Así es como usted puede verificarlo

Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.

Los sitios web seguros .gov usan HTTPS
Un candado (  ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

La información sobre este estudio está en inglés.

Si necesita ayuda en español, comuníquese con el Centro de Educación y Referencias sobre la Enfermedad de Alzheimer y las Demencias Relacionadas (ADEAR, por sus siglas en inglés) por teléfono al 800-438-4380 o envíe un correo electrónico. También puede llamar o enviar un correo electrónico al contacto del estudio (en inglés) para obtener información adicional.

Find more clinical trials

Innovations in Dementia Empowerment and Action

Start: December 5, 2018
End: May 2023
Enrollment: 225

What Is This Study About?

This study will compare two behavioral interventions for lesbian, gay, bisexual, and transgender (LGBT) individuals with Alzheimer's disease or a related dementia and their caregivers. Reducing Disability in Alzheimer's Disease (RDAD) has been used to train individuals with Alzheimer's disease or a related dementia and their caregivers to better manage behavioral symptoms. Researchers will compare RDAD to a similar intervention that addresses LGBT-specific risk factors, including identity management, stigma-related adverse/traumatic life events, and lack of social support. The training involves nine 60-minute, virtual sessions over six weeks, plus four 15-minute, follow-up phone sessions over four months. The program focuses on increasing physical activities of individuals with Alzheimer's and their caregivers and learning to cope with the behavioral components of dementia. Researchers will look at the interventions' effects on behavioral symptoms, physical activity levels, caregiver stress, and quality of life.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: N/A

Must have:

Participants with Dementia

  • Dementia (e.g., Alzheimer's disease, mild cognitive impairment, vascular dementia, Parkinson's disease, Lewy body dementia) or memory loss significant enough to affect daily activities 

Caregivers

  • Unpaid caregiver
  • Willing to commit to 30 minutes each day for study activities or coordinate daily activities for the care recipient

All Participants

  • Either the caregiver and/or dementia care recipient must self-identify as LGBT (or sexual or gender non-binary or same-sex sexual behavior)
  • Living in the community, not in a care facility
  • Living in the United States

Must NOT have:

  • Known terminal illness (with death anticipated within the next 12 months)
  • Hospitalization for a psychiatric disorder in the past 12 months
  • Currently suicidal or having major hallucinations or delusions
  • Plans to move to long-term care setting within six months of study enrollment
  • Any physical limitations or chronic conditions preventing participation in an exercise program

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: University of Washington

Source: ClinicalTrials.gov ID: NCT03550131

 

alzheimers.gov/es

Un sitio web oficial del Gobierno de los Estados Unidos, gestionado por el Instituto Nacional sobre el Envejecimiento, parte de los Institutos Nacionales de la Salud